Skip to content

Evidence brief · hallmark

Dysbiosis

Synthesized from 10 indexed sources · 2026-10-31 MST

Based on the provided sources, there is no mention, data, or discussion regarding "dysbiosis." Sources [1] through [10] pertain to entirely different topics, including psychiatric disorder prevalence [1], sarcopenia definitions and consensus [2, 4], human microbiome structure and geography [3, 7], child growth references [5], global mortality estimates [6], Quaternary ice ages [8], macular edema treatments [9], and NAD+ repletion in chronic kidney disease [10].

Consequently, using only the provided literature, it is not possible to state a scientific consensus, identify open questions, or evaluate the strength of evidence concerning dysbiosis.

Sources

  1. [1] Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
  2. [2] Sarcopenia: revised European consensus on definition and diagnosis
  3. [3] Structure, function and diversity of the healthy human microbiome
  4. [4] Sarcopenia: European consensus on definition and diagnosis
  5. [5] Development of a WHO growth reference for school-aged children and adolescents
  6. [6] Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  7. [7] Human gut microbiome viewed across age and geography
  8. [8] The genetic legacy of the Quaternary ice ages
  9. [9] A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
  10. [10] Effects of NAD⁺ Repletion with Nicotinamide Riboside on Obesity-Induced Chronic Kidney Disease